Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:STSA

Satsuma Pharmaceuticals (STSA) Stock Price, News & Analysis

Satsuma Pharmaceuticals logo

About Satsuma Pharmaceuticals Stock (NASDAQ:STSA)

Advanced Chart

Key Stats

Today's Range
$1.10
$1.10
50-Day Range
$1.04
$1.11
52-Week Range
$0.59
$8.08
Volume
N/A
Average Volume
701,788 shs
Market Capitalization
$36.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive STSA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Satsuma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

STSA Stock News Headlines

Did you miss out on Trump’s “birthday gift” to Americans?
While protestors were rallying against “King Trump,” one trader quietly spotted a 15% weekend move tied to his actions. This setup is part of a larger pattern — one that repeats whenever Trump makes waves. Now, veteran trader Larry Benedict is revealing three “Trigger Tickers” that could deliver 2–3X returns… plus a $194 trillion catalyst that could light up the markets.
Satsuma Pharmaceuticals Inc (STSA)
SNBL’s Subsidiary Resubmits Migraine Drug Application
See More Headlines

STSA Stock Analysis - Frequently Asked Questions

Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) announced its quarterly earnings data on Tuesday, November, 9th. The financial services provider reported ($0.42) EPS for the quarter, beating the consensus estimate of ($0.51) by $0.09.

Satsuma Pharmaceuticals (STSA) raised $75 million in an initial public offering on Friday, September 13th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Credit Suisse, SVB Leerink and Evercore served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Satsuma Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Alphabet (GOOG), JPMorgan Chase & Co. (JPM) and Home Depot (HD).

Company Calendar

Last Earnings
11/09/2021
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Regional Banks
Current Symbol
NASDAQ:STSA
Fax
N/A
Employees
21
Year Founded
2016

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$70.06 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.41 per share
Price / Book
0.78

Miscellaneous

Free Float
22,809,000
Market Cap
$36.47 million
Optionable
Not Optionable
Beta
0.10

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:STSA) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners